Prescription drug · ANDA
Doxycycline Monohydrate NDC 72189-358
Doxycycline 100 mg/1 · Capsule · Oral · Direct_Rx
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72189-358-20 | 72189035820 | 20 CAPSULE in 1 BOTTLE (72189-358-20)Marketed from May 26, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Doxycycline Monohydrate
- Generic name (nonproprietary)
- doxycycline monohydrate
- Active ingredients
- Doxycycline — 100 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Direct_Rx
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 065053
- Marketing start
- Listing expires
- Other FDA classes
- Tetracyclines (Chemical structure)
- Identifiers
- Product ID 72189-358_2c4c8dd5-f079-0339-e063-6394a90afedbSPL ID 2c4c8dd5-f079-0339-e063-6394a90afedbSPL set ID dfef600c-bceb-fbc9-e053-2a95a90ae6c0RxCUI 1649990UNII N12000U13O
- Pharmacologic class
- Tetracycline-class Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472189035820followed by a unit qualifier and the quantityPackage 72189-0358-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline capsules, USP and other antibacterial drugs, doxycycline capsules, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Doxycycline capsules, USP are indicated for the treatment of the following infections: Rocky Mountain spotted fever, typhus fever and the typhus …
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 065053
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Doxycycline | Doxycycline 50 mg/1 | CapsuleOral | Sun Pharmaceutical Industries, Inc. | 63304-614 |
| Doxycycline | Doxycycline 75 mg/1 | CapsuleOral | Sun Pharmaceutical Industries, Inc. | 63304-615 |
| Doxycycline | Doxycycline 100 mg/1 | CapsuleOral | Sun Pharmaceutical Industries, Inc. | 63304-616 |
| Doxycycline | Doxycycline 100 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-1988 |